GET TO KNOW OUR EXPERIENCED MANAGEMENT TEAM

ZALÁN
PÉTERFI

ZALÁN’S ROLE IS TO BUILD THE VRG Tx TEAM AND TO OVERSEE THE COMPANY’S OPERATIONS

Zalán is a Harvard-trained scientist, ex-Mckinsey consultant with extensive experience in the pharma and biotech industry. He is passionate about and experienced in topics where both scientific/medical expertise and management/business excellence are essential to drive maximum impact. He is a life-science focused leader with the ability to recruit, train, and manage high-performing teams demonstrated by 10+ years of leadership in academic and business settings.

SÁNDOR
FARKAS

SÁNDOR’S ROLE IS TO ENSURE THAT SCIENCE IS IN LINE WITH INDUSTRIAL STANDARDS AND HE IS RESPONSIBLE FOR IP STRATEGY AND EXECUTION.

Sándor is a non-clinical pharmacologist and drug development scientist, with over 33 years of experience in the pharma Industry. He worked as a research scientist at the University of Tokyo, Japan. His special areas of expertise include all phases of early drug development from target identification to non-clinical support of clinical development. He provided training and education in the discipline of pharmaceutical medicine. Author of 39 scientific publications and inventor of 23 patent applications involving 6 drug candidates that reached clinical development.

ATTILA
BRUNYÁNSZKI

Attila keeps the laboratory operations running smoothly.

He is a biologist-biotechnologist with Ph.D. in molecular biology and a certified TSTM (Translational Science Team Management) that gained during postdoctoral fellow at UTMB, Texas, USA. He has more than 10 years of experience in molecular biology, biotechnology and cell biology in the field of life sciences research with more than 20 international publications and over 1,000 citations. He is an experienced lead scientist and project manager in the field of biotechnology and pharmaceutical R&D with 5+ years.

TAMÁS
KITKA

TAMÁS IS RESPONSIBLE FOR PORTFOLIO STRUCTURE AND PROGRESS AND FOR SCIENTIFIC STRATEGY AND IMPLEMENTATION.

He is a pharmaceutical R&D expert and holds a PhD in Neurobiology. He has 10+ years of experience in the pharmaceutical industry in various positions: researcher/developer, project manager, research team leader, and business development manager. His experience embraces the full non-clinical R&D process in various types of projects (small molecules, biologics, etc.). He participated several projects in either research or development phase that have later been tested in clinical trials.

MÁRTON
MEGYERI

MÁRTON IS RESPONSIBLE FOR SCIENTIFIC STAFF MANAGEMENT AS WELL AS CHEMISTRY MANUFACTURING AND CONTROLS (CMC) AND REGULATORY AFFAIRS.

Márton is a Weizmann Institute-trained scientist with a primary degree in bioengineering and a PhD in structural biochemistry. He has 15+ years of academic track record and 10+ years of industrial biotechnology R&D experience with Chemistry, Manufacturing, and Controls (CMC) and Regulatory expertise. He possesses hands-on experience in biologics drug substance and drug product development, along with supporting analytics. Márton has participated in several BPD Type 2 meetings with the FDA and has driven successful IND submissions.

TAMÁS
CSIKAI

TAMÁS IS RESPONSIBLE FOR FINANCIAL AND OPERATIONAL STABILITY AS WELL AS INVESTOR RELATIONS.

Tamás holds a degree in finance and accounting from the Corvinus University of Budapest and has 10+ years of finance, strategy and operations experience. He started his career at KBC Group as a corporate finance analyst. Later he was a management consultant at McKinsey and Company. Recently, he was a subsidiary finance and operations director at OTP Group. He has previously laid the strategy and successfully built a new venture at OTP Group from scratch via a mix of organic and inorganic (M&A) activities.

PÉTER
KOVÁCS

PÉTER IS RESPONSIBLE FOR IN VIVO STUDY DESIGN AND EXECUTION.

Peter is an experienced preclinical pharmacologist. He earned his MSc in biology, BSc in Chemistry and PhD in Neuropharmacology from the University of Pécs. He subsequently studied and worked as an academic researcher for 5 years at Penn State University, in the USA. He has more than 10 years of experience in the pharmaceutical industry, including researcher and management roles in early drug discovery, clinical trials and medico-marketing drug positioning. He also works as an Assistant Professor at Semmelweis University, Faculty of Medicine, Department of Pharmacology and Pharmacotherapy.